AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SELLAS Life Sciences Group, Inc. Director's Dealing 2017

Dec 29, 2017

33651_dirs_2017-12-29_576eea71-ce60-42d1-b259-088f0bc09a09.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2017-12-29

Reporting Person: Sarlis Nicholas J. (Chief Medical Officer and SVP)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct